The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies

Abstract

Uncertainty about whether biologics could increase the risk of SARS-CoV-2 infection led to drug withdrawal with subsequent worsening of psoriasis. Moreover, psychological status also had a direct influence on the clinical course of the disease.